Has anyone heard of or is anyone taking Cylert or Pemoline?

I have started taking it but I am having trouble finding anyone who has heard of it.

Thanks,

Jennifer :bouncing:

My son took Cylert about 4 years ago until I found out he needed a blood test every 6 weeks with this drug. So I asked to switch to something else. It was linked to liver problems in some patients. That may be why it isn't much used anymore.

if you look up cylert or pemoline it has numerous warnings about it causing liver failure and death,even after you stop taking it.the doctor is supposed to go over the risks of taking cylert and have you sign a consent form saying you realize the risks and accept them,also it states that cylert is not to be used as the first treatment because of the dangers involved.i went to a psyche and he tried to put me on cylert,when i asked why he was putting me on such a risky drug instead of ritilin he replied cylert is a schedul 4 drug and ritilin is a schedule 2 drug and he didn't want the dea coming into his office.i left his office and went to a psyche that treats children with add and he put me back on ritilin and said he would never use cylert because of the dangers of liver failure and death.look up cylert and make up your own mind.

Because of its association with life threatening hepatic failure, CYLERT should not ordinarily be considered as first line drug therapy for ADHD (see INDICATIONS AND USAGE). [this drug has been withdrawn from the market in march 2005]
Since CYLERT’s marketing in 1975, 13 cases of acute hepatic failure have been reported to the FDA. While the absolute number of reported cases is not large. the rate of reporting ranges from 4 to 17 times the rate expected in the general population. This estimate may be conservative because of under reporting and because the long latency between initiation of CYLERT treatment and the occurrence of hepatic failure may limit recognition of the association. If only a por-tion of actual cases were recognized and reported, the risk could be substantially higher.

Of the 13 cases reported as of May 1996, 11 resulted in death or liver transplantation, usually within four weeks of the onset of signs and symptoms of liver failure. The ear-liest onset of hepatic abnormalities occurred six months after initiation of CYLERT. Although some reports described dark urine and nonspecific prodromal symptoms (e.g., anorexia, malaise, and gastrointestinal symp-toms), in other reports it was not clear if any prodromal symptoms preceded the onset of jaundice. It is also not clear if the recom-mended baseline and periodic liver function testing are predictive of these instances of acute liver failure. CYLERT should be dis-continued if clinically significant hepatic dysfunction is observed during its use
i hope this info is helpfull to you.